Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd share price and stock overview

Glenmark Pharmaceuticals Ltd (NSE: GLENMARK, BSE: 532296) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE935A01035 and a face value of Rs 1. As of 28 July 2026, it trades at Rs (2,184.60) with a market capitalisation of Rs 61927.56 crore. Figures are live and subject to change.

Glenmark Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
2,184.60 -11.40 (-0.52%) downArrowC
As on: 28-Jul-2026 , 06:19 PM
Market Cap(₹Cr) 61927.56
Book Value(₹Cr) 855.7849313
BSE Code : 532296 NSE Symbol : GLENMARK EPS(TTM) : 56.7 ISIN Demat : INE935A01035 P/E(TTM) : 38.7 Face Value(₹) : 1 Div & Yield % : 0.11

Today Market

Stock Performance

Today Market

Today's High

76,988.48

Todday's Low

76,672.77

Open at

76,831.75

Previous Close

76,835.78

Volumes

Avg Price

-69.86

Historical Performance

News

21 Jul 26
Glenmark receives USFDA approval for expanded use of RYALTRIS' for pediatric patients
Glenmark Specialty S.A. (Glenmark) today announced that U.S. FDA has approved the expanded use of RYALTRIS' (olopatadine hydrochloride and mometasone furoate) Nasal Spray, 665 mcg/25 mcg per spray, for the treatment of symptoms of Seasonal Allergic Rhinitis (SAR) in pediatric patients aged 6 to less than 12 years.
16 Jul 26
Glenmark Pharmaceuticals announces board meeting date
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 31 July 2026.
15 Jul 26
Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 2307, up 0.
06 Jul 26
Glenmark Pharmaceuticals Ltd stays supported
Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 2260.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
27-07-26 2218.00 2220.00 2183.10 2196.00 593586 21803 1306301382.10 23995.95
24-07-26 2182.00 2248.80 2182.00 2192.00 429562 15211 942167256.80 23767.45
23-07-26 2185.10 2241.30 2182.80 2205.10 567718 24176 1256368329.90 23869.60
22-07-26 2229.80 2229.80 2166.00 2199.90 942175 35812 2072087800.30 23996.25
21-07-26 2245.80 2249.30 2221.10 2242.10 274753 15601 614303550.10 24187.70
20-07-26 2235.00 2270.00 2225.30 2239.50 914679 27300 2050749666.90 24238.50
17-07-26 2287.90 2287.90 2229.00 2235.50 355968 19641 799824718.00 24334.30
16-07-26 2313.00 2313.00 2280.10 2286.90 158181 14441 362106258.00 24072.75
15-07-26 2316.00 2318.90 2285.60 2297.40 491365 21154 1131486261.80 24078.50
14-07-26 2309.00 2326.10 2293.00 2305.10 706821 25949 1635028649.20 24052.05
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

61927.56

PE Ratio

38.7

PB Ratio

2.56

Dividend Yield

0.11

ROE

6.78

ROCE

8.94

Book Value (₹)

855.7849313

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3415386 1.21 3415386 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128241936 45.44 128241936 1
Others 0 0.00 0 0
Sub Total 131657322 46.65 131657322 6
Total ShareHolding for Promoter & Group 131657322 46.65 131657322 6
plus   Publice Share Holding
plus  Institution
Government(Central / State) 107037 0.04 107037 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 290043 0.10 290043 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 58959712 20.89 58959712 376
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2866650 1.02 2866650 18
Mutual Funds / UTI 47294735 16.76 47294735 37
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2050205 0.73 2050205 36
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 111568382 39.54 111568382 473
plus  Non Institution
Bodies Corporate 5857675 2.08 5857675 1330
Clearing Members 637 0.00 637 5
Directors & their Relatives 35 0.00 35 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2319787 0.82 2315787 6325
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 541779 0.19 541779 3551
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7595046 2.69 6995046 14
Individuals holding nominal share capital up to Rs. 1 lakh 22308732 7.91 22101398 199701
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 64236 0.02 64236 9
Others 287178 0.10 287178 3
Sub Total 38975105 13.81 38163771 210939
Total Public Shareholding 150543487 53.35 149732153 211412
Total of Promoter & Public ShareHolding 282200809 100.00 281389475 211418
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 282200809 100.00 281389475 211418

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales13,321.7411,813.1011,583.2412,304.9010,943.93
OPM (%)13.307.948.6813.8312.23
OP1,772.03937.451,005.701,702.161,337.93
Other Income113.72839.99288.90166.6750.22
PBIDT2,092.281,134.371,158.052,226.062,179.14
INTEREST207.07515.97349.04298.10353.11
PBDT1,885.22618.40809.021,927.961,826.03
PBT1,026.39-864.46-526.011,180.331,427.02
EO-372.82-900.96-765.85-260.9144.55
PBT after EO1,399.2136.50239.841,441.251,382.48
TAXES352.071,867.35329.40447.60412.39
PAT1,047.10-1,501.67297.25941.71970.04
EPS37.11-53.2210.5333.3734.38
Raw Material22.5326.7327.5026.6527.95
Power and Fuel0.780.790.751.471.30
Employee Cost22.6924.2822.4519.8921.42
Other Manufacturing Expenses0.671.060.600.600.41
Selling and Administration Expenses14.8214.4115.1312.5413.28
Miscellaneous Expenses5.916.425.575.665.84
Revenue (Growth %) 12.771.98-5.8612.442.85
PBIDT (Growth %)84.44-2.04-47.982.1515.26
PAT (Growth %) -169.73-605.20-68.44-2.9225.01
PBIDT (Margin %)15.719.6010.0018.0919.91
PAT (Margin %) 7.86-12.712.577.658.86

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 28.2228.2228.2228.2228.2228.22
Reserves Total 24475.7422942.4017849.2516710.3714781.2913198.05
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds24503.9622970.6217877.4716738.5914809.5113226.27
Secured Loans 298.820.000.000.000.000.00
Unsecured Loans 530.97707.293221.223737.703703.993573.76
Total Debt829.79707.293221.223737.703703.993573.76
Other Liabilities132.10131.94372.58121.32136.61205.65
Total Liabilities25465.8523809.8521471.2720597.6118650.1117005.68
APPLICATION OF FUNDS :
Gross Block 3743.153392.753183.653026.282848.562595.06
Less : Accumulated Depreciation 1763.971636.501437.701273.951126.07983.11
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1979.181756.251745.951752.331722.491611.95
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress154.56197.67172.34109.04131.40200.01
Producing Properties0.000.000.000.000.000.00
Investments 15194.9112964.7910334.018559.396989.954713.93
Current Assets, Loans & Advances
Inventories 1369.311142.691090.21951.66762.39837.50
Sundry Debtors 2550.162484.472505.662678.322488.751835.24
Cash and Bank Balance132.74129.1593.7929.6315.7988.26
Loans and Advances 725.47925.17695.51743.311642.201662.89
Total Current Assets4777.684681.484385.184402.934909.124423.89
Less : Current Liabilities and Provisions
Current Liabilities 2383.393249.792952.142168.391834.311827.48
Provisions 125.79354.74162.52148.49133.11118.45
Total Current Liabilities & Provisions2509.183604.543114.662316.881967.411945.92
Net Current Assets2268.501076.941270.522086.052941.712477.97
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets166.59475.611160.251137.471118.721081.34
Deferred Tax Liability224.85309.77213.50214.20265.43276.60
Net Deferred Tax-58.26165.84946.75923.27853.29804.74
Other Assets5926.977648.377001.707167.546011.277197.08
Total Assets25465.8623809.8521471.2620597.6218650.1117005.68
Contingent Liabilities2949.432658.493443.303325.063730.174430.59

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -80.79-305.12-978.50-2,666.45-95.41
Investing Activities -1,235.19-897.02-431.523,197.17-489.90
Net Cash Flow -72.5713.9364.0535.273.49
Operating Activities 1,243.421,216.071,474.06-495.45588.80

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
GS
Glenn Saldanha
Chairman / Executive Director / M D / Promoter
Executive
Functional Directors
BES
B E Saldanha
Non Executive Director
Exec.
Independent Directors
SSR
Sona Saira Ramasastry
Independent Non Exe. Director
Ind.
DB
Dipankar Bhattacharjee
Independent Non Exe. Director
Ind.
VRI
V R Iyer
Independent Non Exe. Director
Ind.
PKS
Pradeep Kumar Sinha
Independent Non Exe. Director
Ind.
Other Officials
CP
Cheryl Pinto
ED / WTD / Promoter
Board
AM
Anurag Mantri
ED / President / Global CFO
Board
HK
Harish Kuber
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Glenmark Pharmaceuticals Ltd? −

Glenmark Pharmaceuticals Ltd trades on NSE under GLENMARK and on BSE under code 532296. The ISIN is INE935A01035 and the face value is Rs 1.

What is the share price of Glenmark Pharmaceuticals Ltd today? +

As of 28 July 2026, Glenmark Pharmaceuticals Ltd trades at Rs 2,184.60, a change of -11.40 (-0.52%) on the day. Prices are live and subject to change.

What is the market capitalisation of Glenmark Pharmaceuticals Ltd? +

As of 28 July 2026, Glenmark Pharmaceuticals Ltd has a market cap of about Rs 61927.56 crore. This figure is live and moves with the share price.

Is Glenmark Pharmaceuticals Ltd profitable? +

In March 2025, Glenmark Pharmaceuticals Ltd reported a profit after tax of Rs 1,047.10 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Glenmark Pharmaceuticals Ltd? +

: As of 28 July 2026, the PE (TTM) for Glenmark Pharmaceuticals Ltd is 38.7 and the price-to-book ratio is 2.56. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Glenmark Pharmaceuticals Ltd pay a dividend? +

As of 28 July 2026, the dividend yield for Glenmark Pharmaceuticals Ltd is 0.11%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Glenmark Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 46.65% of Glenmark Pharmaceuticals Ltd. Public shareholding is 53.35%, including mutual funds at 16.76% and foreign institutional investors at 20.89%.

What were the latest annual financials of Glenmark Pharmaceuticals Ltd? +

In March 2025, Glenmark Pharmaceuticals Ltd reported net sales of Rs 13,321.74 crore, revenue growth of 12.77%, and earnings per share of Rs 37.11.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web